[Ginkgo biloba in treatment of intermittent claudication. A systematic research based on controlled studies in the literature]
[Ginkgo biloba in treatment of intermittent claudication. A systematic research based on controlled studies in the literature]
Ernst et al., 1996 | Fortschr Med | Systematic Review
Citation
Ernst E. [Ginkgo biloba in treatment of intermittent claudication. A systematic research based on controlled studies in the literature]. Fortschr Med. 1996-Mar-20;114(8):85-7
Abstract
The aim of this systematic review was to evaluate the effectiveness of ginkgo biloba in the treatment of intermittent claudication. A Medline-search identified ten controlled trials on the subject. These were heterogeneous in all respects and, with only few exceptions, of poor methodological quality. All the studies implied that ginkgo biloba is an effective therapy for intermittent claudication. This hypothesis should be confirmed in further trials employing meticulous methodology. Furthermore it would also be important to determine whether oral ginkgo biloba can be usefully combined with walking exercise.
Key Findings
Furthermore it would also be important to determine whether oral ginkgo biloba can be usefully combined with walking exercise.
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | See abstract |
| Sample Size | See abstract |
| Age Range | See abstract |
| Condition | See abstract |
MeSH Terms
- Clinical Trials as Topic
- Diterpenes
- Double-Blind Method
- Fibrinolytic Agents
- Ginkgolides
- Humans
- Intermittent Claudication
- Lactones
- Randomized Controlled Trials as Topic
- Treatment Outcome
Evidence Classification
- Level: Systematic Review
- Publication Types: Journal Article, Systematic Review
- Vertical: ginkgo
Provenance
- PMID: 8647571
- DOI: (not available)
- PMCID: Not in PMC
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09